Preoperative albumin-bilirubin score predicts short-term outcomes and long-term prognosis in colorectal cancer patients undergoing radical surgery

doi:10.4240/wjgs.v16.i7.2096

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (819)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

WORD

HTML

384

Figures (1-3)

Tables (1-5)

Sum=579

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

167

Sum=210

Jul 27, 2024 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Jul 27, 2024; 16(7): 2096-2105
Published online Jul 27, 2024. doi: 10.4240/wjgs.v16.i7.2096

Preoperative albumin-bilirubin score predicts short-term outcomes and long-term prognosis in colorectal cancer patients undergoing radical surgery

Yu-Hang Diao, Xin-Peng Shu, Can Tan, Li-Juan Wang, Yong Cheng

Yu-Hang Diao, Xin-Peng Shu, Can Tan, Li-Juan Wang, Yong Cheng, Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China

Co-first authors: Yu-Hang Diao and Xin-Peng Shu.

Author contributions: Diao YH and Shu XP contributed to the data analysis; Cheng Y led the quality assessments; Diao YH wrote the original draft; Shu XP and Cheng Y revised the manuscript. The data was gathered by all the authors. All authors have agreed on the manuscript to be submitted, provided final approval of the version to be published, and agree to be responsible for all elements of the work. Diao YH and Shu XP contributed equally to this work.

Institutional review board statement: This study was reviewed and approved by the Ethics Committee of The First Affiliated Hospital of Chongqing Medical University.

Informed consent statement: This is a retrospective study, and the patients came from a teaching hospital of the First Affiliated Hospital of Chongqing Medical University. When we delivered the ethics application, we also delivered application for exemption of informed consent.

Conflict-of-interest statement: The authors declare no conflicts of interest for this article.

Data sharing statement: The datasets generated and/or analyzed during the current study are not publicly available due but are available from the corresponding author upon reasonable request.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Yong Cheng, PhD, Chief Doctor, Professor, Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuanjiagang, Yuzhong District, Chongqing 400016, China. chengyongcq@163.com

Received: March 10, 2024
Revised: May 9, 2024
Accepted: June 5, 2024
Published online: July 27, 2024
Processing time: 134 Days and 0.6 Hours

Core Tip

Core Tip: The albumin-bilirubin (ALBI) scoring system is an objective and convenient method for evaluating liver function, and its prognostic value in a variety of cancers has been gradually recognized. In this study, patients who underwent radical surgery for colorectal cancer (CRC) were enrolled and divided into a high-ALBI score group (ALBI score > -2.8) and a low-ALBI score group (ALBI score ≤ -2.8) according to the cutoff calculated with X-tile software, and the results showed that the ALBI score is an independent risk factor for overall survival and disease-free survival in CRC patients undergoing radical resection.